These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39397222)

  • 1. USP5 Stabilizes IKBKG Through Deubiquitination to Suppress Ferroptosis and Promote Growth in Non-small Cell Lung Cancer.
    Li Y; Qiu G; Zhou M; Chen Q; Liao X
    Cell Biochem Biophys; 2024 Oct; ():. PubMed ID: 39397222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
    Zhang Z; Cui Z; Xie Z; Li C; Xu C; Guo X; Yu J; Chen T; Facchinetti F; Bohnenberger H; Leong TL; Xie Y; Mao X; Zhao J
    Transl Lung Cancer Res; 2021 Oct; 10(10):3995-4011. PubMed ID: 34858787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin-specific protease 5 mediated deubiquitination of LSH links metabolic regulation of ferroptosis to hepatocellular carcinoma progression.
    Yan B; Guo J; Wang Z; Ning J; Wang H; Shu L; Hu K; Chen L; Shi Y; Zhang L; Liu S; Tao Y; Xiao D
    MedComm (2020); 2023 Aug; 4(4):e337. PubMed ID: 37492786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of USP5 contributes to tumorigenesis in non-small cell lung cancer via the stabilization of β-catenin protein.
    Ma X; Qi W; Pan H; Yang F; Deng J
    Am J Cancer Res; 2018; 8(11):2284-2295. PubMed ID: 30555744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PFKP deubiquitination and stabilization by USP5 activate aerobic glycolysis to promote triple-negative breast cancer progression.
    Peng ZM; Han XJ; Wang T; Li JJ; Yang CX; Tou FF; Zhang Z
    Breast Cancer Res; 2024 Jan; 26(1):10. PubMed ID: 38217030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP22 promotes gefitinib resistance and inhibits ferroptosis in non-small cell lung cancer by deubiquitination of MDM2.
    Lu P; Li Z; Xu H
    Thorac Cancer; 2024 Nov; 15(31):2260-2271. PubMed ID: 39315600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination.
    Guo H; Liu R; Lv H; Huo Q; Yao Y; Lu X
    Cell Signal; 2024 Aug; 120():111225. PubMed ID: 38735506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis.
    An J; Shi J; Yang C; Luo J; Li Y; Ren J; Lv Y; Zhang Y
    Mol Cell Biochem; 2024 Aug; 479(8):2143-2155. PubMed ID: 37639200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deubiquitinase USP5 promotes cholangiocarcinoma progression by stabilizing YBX1.
    Ning F; Du L; Li J; Wu T; Zhou J; Chen Z; Hu X; Zhang Y; Luan X; Xin H; Yuan C; Zhang X
    Life Sci; 2024 Jul; 348():122674. PubMed ID: 38692507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0082374 Promotes the Tumorigenesis and Suppresses Ferroptosis in Non-small Cell Lung Cancer by Up-Regulating GPX4 Through Sequestering miR-491-5p.
    Li Z; Fan M; Zhou Z; Sang X
    Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38438754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF‑1α inhibits ferroptosis and promotes malignant progression in non‑small cell lung cancer by activating the Hippo‑YAP signalling pathway.
    Zheng S; Mo J; Zhang J; Chen Y
    Oncol Lett; 2023 Mar; 25(3):90. PubMed ID: 36817050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis.
    Chen H; Wang L; Liu J; Wan Z; Zhou L; Liao H; Wan R
    Cancer Biol Ther; 2023 Dec; 24(1):2223377. PubMed ID: 37370246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma.
    Meng J; Ai X; Lei Y; Zhong W; Qian B; Qiao K; Wang X; Zhou B; Wang H; Huai L; Zhang X; Han J; Xue Y; Liang Y; Zhou H; Chen S; Sun T; Yang C
    Theranostics; 2019; 9(2):573-587. PubMed ID: 30809294
    [No Abstract]   [Full Text] [Related]  

  • 15. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
    Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
    Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.
    Xu X; Huang A; Cui X; Han K; Hou X; Wang Q; Cui L; Yang Y
    Theranostics; 2019; 9(14):4208-4220. PubMed ID: 31281542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis.
    Tao R; Liu Z; Zhang Z; Zhang Z
    Anticancer Drugs; 2024 Jul; 35(6):483-491. PubMed ID: 38502867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
    Zhang HH; Zhang AQ; Peng P; Huang L; Liu CY; Nie XR; Hou DF; Zhang X; Li SZ
    Cancer Cell Int; 2024 Jan; 24(1):32. PubMed ID: 38229092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
    Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
    J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EOAI, a ubiquitin-specific peptidase 5 inhibitor, prevents non-small cell lung cancer progression by inducing DNA damage.
    Zheng Y; Wang L; Niu X; Guo Y; Zhao J; Li L; Zhao J
    BMC Cancer; 2023 Jan; 23(1):28. PubMed ID: 36611139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.